The Indian patents act 1970 was amended in 2005 with the aim to keep medicines and healthcare affordable to the citizens. However because of this the Indian industry has drawn flak from the global pharmaceutical industry including from US and European Union. At the heart of the matter is, strong patent measures, which India has established in line with the World Trade Organization (WTO) norms.
However, it is also noteworthy that India today is considered a giant in pharmaceuticals. This is India’s fastest growing industrial sector with a double digit growth figure. India at present is the world’s second largest exporter of pharmaceuticals, and is considered pharmacy of the poor world. The most astonishing fact is US it-self is one of the largest markets of generic medicines produced in India.
- Intellectual property rights and Indian pharmaceutical industry: Present scenario
- How India rejects bad patents
- Patents and protecting public health
- The elephant in the Patent Office
- U.S. wants patent form recall
- This is about life and death’: Pharmaceutical patents threaten India’s generic drug industry
- Patent considerations
- An urgent prescription
- Patent error
- Fewer women researchers file for patents globally: Study
- Outside the patent monopolies
- Patents over patients